Tuesday, 21 May 2019

Pharma News

  • Bayer initiates Phase II/III trial of a new compound for Hemophilia A

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hem...Read more

  • GlobalData: Osteoporosis market to be $8 bn

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the UK, Japan, China, and India will reach a value of $8 billion in 2022 ...Read more

  • Cipla gets drug pricing breather from Delhi Court

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: India's Delhi High Court has extended the operation of its earlier order asking the central government not to take coercive steps against pharma major Cipla. The company was tol...Read more

  • Malaysia a hotbed for medical tourism'

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2014

    Singapore: Medical tourism, easy regulatory guidelines, a lack of strict price regulation and an increasing elderly population will be the main contributors to the rapid rise in Malaysia's ...Read more

  • R-Tech Ueno loses case against Takeda

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2012

    Singapore: The International Court of Arbitration, International Chamber of Commerce, has issued its arbitral award in the arbitration filed by R-Tech Ueno, together with Sucampo Pharmaceut...Read more

  • APAC ovarian cancer drug market to grow modestly'

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

    Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth...Read more

  • China Botanic reports Q3 2012 results

    Pharma |  Company results | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

    Singapore: China Botanic Pharmaceutical revealed its financial results for the three months ending July 31, 2012. During the third quarter (Q3) of fisal year 2012, net revenue increased by ...Read more

  • Atrial fibrillation management is suboptimal and unequal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: New one-year follow-up results from the global RE-LY AF registry shows that 11.7 percent of patients with atrial fibrillation (AF) who were included in the registry from January ...Read more

  • Deal with Janssen gets Astellas $65 million up-front

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2012

    Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to develop and commercialize ASP015K, an Astellas compound, worldwide e...Read more

  • Takeda acquires URL Pharma

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jun, 2012

    Singapore: Takeda Pharmaceutical Company acquired URL Pharma through its wholly-owned subsidiary Takeda America Holdings (TAH), for an upfront payment of $800 million in cash and future per...Read more

  • Indian Government strengthens clinical trials regulations

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Bangalore: In a bid to strengthen the regulation and monitoring of clinical trials in the country, the Indian Government has announced several measures to strengthen the regulation and moni...Read more

  • Taiwan approves gout drug febuxostat

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

    Singapore: Taiwan's Department of Health has approved marketing of febuxostat, a novel drug developed for the treatment of hyperuricemia with gout, in the country. Febuxostat has been devel...Read more

  • Research and Markets offers new report on China pharma industry

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Singapore: Research and Markets has added a report on China Pharmaceutical Machinery Industry to their offering. This report first gives an overview of the pharmaceutical machinery industr...Read more

  • China Biologics appoint David Gao to additional post of CEO

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    China Biologic Products, one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, has appointed Chairman Mr David (Xiaoying) Gao to the additional pos...Read more

  • Dishman Pharma records 13.2% growth

    Pharma |  Company results | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Bangalore: Dishman Pharma has posted a 13.24 percent growth in the fourth quarter of FY12 and reported a consolidated net profit of Rs 312.94 million for the quarter ended 31 March, 2012, u...Read more

  • Dr. Reddy's revenues cross $2 billion milestone

    Pharma |  Company results | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Hyderabad: Dr. Reddy's Laboratories announced its audited consolidated financial results for the quarter and full year ended March 31, 2012 under International Financial Reporting Standards...Read more

  • BMS announces Q2 2012 results

    Pharma |  Company results | By BioSpectrum Bureau  | 0 Comment | 26 Jul, 2012

    Singapore: Bristol-Myers Squibb (BMS) reported results for the second quarter (Q2) of 2012 and also adjusted its GAAP EPS guidance range and confirmed its non-GAAP EPS guidance range for 20...Read more

  • US FDA approves Suprax 400 mg by Lupin

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Mumbai: Lupin Pharmaceuticals, a subsidiary of India-based Lupin, has received approval for Suprax (Cefixime) Capsules 400 mg from the US Food and Drugs Administration (FDA). A statement re...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls